88 Episodes

  1. Tim Vanuytsel on spore-forming probiotics in functional dyspepsia

    Published: 9/9/2021
  2. Raymond Henderson on the economic burden of colorectal cancer

    Published: 8/12/2021
  3. Sigurður Ólafsson on eliminating hepatitis C in Iceland

    Published: 6/22/2021
  4. Caroline Ovadia on intrahepatic cholestasis of pregnancy

    Published: 6/3/2021
  5. Matthew Akiyama on hepatitis C in prisons

    Published: 4/12/2021
  6. Monika Sarkar on reproductive health in women with liver disease

    Published: 3/11/2021
  7. Colorectal cancer risk in patients with Crohn’s disease

    Published: 3/12/2020
  8. Liver damage in young adults

    Published: 1/17/2020
  9. Treatments for IBS

    Published: 1/14/2020
  10. Statins and decompensated cirrhosis

    Published: 11/27/2019
  11. Global burden of pancreatic cancer and colorectal cancer

    Published: 11/4/2019
  12. Paediatric inflammatory bowel disease

    Published: 9/12/2019
  13. Transplanting hepatitis C-infected hearts

    Published: 8/28/2019
  14. Primary anastomosis as a treatment for diverticulitis

    Published: 7/31/2019
  15. Faecal microbiota transplantation in IBS

    Published: 7/30/2019
  16. Treating faecal incontinence in women

    Published: 7/17/2019
  17. Viral hepatitis in children & adolescents

    Published: 5/23/2019
  18. Whole-body MRI: the STREAMLINE trials

    Published: 5/11/2019
  19. A new drug for short bowel syndrome

    Published: 4/5/2019
  20. Eosinophilic oesophagitis endotype classification

    Published: 3/9/2019

3 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.